Biogen Inc. 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-07 4:48 pm Sale |
2024-10-30 | 13G | Denali Therapeutics Inc. DNLI |
BIOGEN IDEC INC. BIIB |
7,155,243 4.970% |
-5,596,122 (-43.89%) |
Filing |
| 2024-02-12 7:07 pm Sale |
2023-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BIOGEN IDEC INC. BIIB |
12,751,365 9.230% |
-558,878 (-4.20%) |
Filing |
| 2020-09-28 4:11 pm Purchase |
2020-09-22 | 13G | Denali Therapeutics Inc. DNLI |
BIOGEN IDEC INC. BIIB |
13,310,243 11.160% |
13,310,243 (New Position) |
Filing |